Renovaro Biosciences (RENB) Q1 2024 Earnings

15MayConfirmed
Q4 2022
Q1 2023
Q4 2023
Q1 2024
-1.7
-1.13
-0.57
0

Details

Expected EPS
N/A
Actual EPS
-0.16
Surprise EPS
-0.16
Surprise Percent
+∞%

Description

Renovaro Biosciences (RENB) has reported earnings of -0.16 per share for Q1 2024.

0 Comments

Share your thoughts